Glopharma SRL
Glopharma reported total assets of €3.60m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).
The score of Glopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +45 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Glopharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Glopharma's financial analysis
- Solvency58.7%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Glopharma
Glopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0819.017.223
- VAT number
- BE0819017223
- Peppol
- Registered · 0208:0819017223 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Sep 2009
- Registered office
- 8550 Zwevegem
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Glopharma (SRL) has been based in Zwevegem since 2009, active in: activities of holding companies. For 2025, it reports a net profit of 222,275 € and equity of €2.12m; its revenue is not published. Its solvency stands at 58.7%, above the median of its sector (55.6%).
Companies similar to Glopharma
Companies in the same business, of comparable size and area, outside its group.
- Aganju Holding Activities of holding companies Etterbeek · balance sheet €6.74m
- ECG Labs Activities of holding companies Lummen · balance sheet €2.64m
- 3K2P Diagnostic imaging services and medical laboratory activities Kortrijk · balance sheet €4.39m
- VAN Goethem Diagnostic imaging services and medical laboratory activities Sint-Niklaas · balance sheet €3.59m
- Spiba Activities of holding companies Ravels · balance sheet €4.29m
- Beele-Drieghe Activities of holding companies Kortrijk · balance sheet 420,178 €
- Ambelin Holdings Business and other management consultancy activities Ganshoren · balance sheet €2.19m
- DR. Verleyen - DR. Delbeke Medical specialists activities Oostkamp · balance sheet €3.19m
Frequently asked questions about Glopharma
What is the revenue of Glopharma?
Glopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Glopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0819017223 for Glopharma, if the company is VAT-registered. Its company number (CBE) is 0819.017.223.
Where is the registered office of Glopharma?
According to the CBE register, the registered office of Glopharma is in 8550 Zwevegem.
What is the equity of Glopharma?
At the close of the 2025 financial year, the equity of Glopharma amounts to 2,116,572 €, a solvency of 58.7% of total assets.
Who manages Glopharma?
The register lists 2 active mandates at Glopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Glopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →